|
|
 |
|
Viewing report
|
|
|
|
The Worldwide Prescription Drug Market 2004
Fuji-Keizai USA, Inc, Nov 2003, Pages: 133
This report is about the worldwide market for human prescription drugs as it transitions through 2003. The study provides readers with recent information and analysis about key developments driving the industry. The research reviews the broad areas of major company activities ranging from planning new drugs with disease demographics, through to strategic alliances, and market forecasts. The report reviews the challenges of patent expirations, developing new drug pipelines and what companies must do to get their drugs approved around the world. A review of price/cost aspects and drug distribution approaches uncovers the kinds of business activities that the pharma companies must do the market their products through to the end patients in different countries.
Target Diseases
Major Disease and the Disease Breakdown
Cancer
Colorectal cancer, Breast cancer, Lung/airway cancers, Prostate cancer, Bladder cancer, Lymphomas, Multiple myeloma, Stomach cancer, Melanoma and other skin cancers, Uterine cancer, Pancreas cancer, Leukemia, Liver cancer, Ovarian cancer, Mouth and throat cancers, Esophagus cancer, Cervical cancer
Cardiovascular
Ischemic heart disease (angina heart attack), Cerebrovascular disease (stroke), Other cardiovascular diseases, Hypertensive heart disease (angina, CHD), Inflammatory heart disease (from Infection)
Central Nervous System (CNS)
Migraine, Depressive disorders, Alcohol use disorders, Alzheimer and other dementias, Insomnia (primary), Drug use disorders, Epilepsy, Bipolar disorder, Schizophrenia, Panic disorder, Obsessive-compulsive disorder, Post-traumatic stress disorder, Parkinson disease, Multiple sclerosis
Gastro-Intestinal
Misc. digestive diseases, GERD, etc, Peptic ulcer disease, Cirrhosis of the liver, Appendicitis
Infections
Tuberculosis, STDs excluding HIV, Chlamydia, Gonorrhea, Syphilis, HIV/AIDS, Diarrheal diseases, Childhood diseases, Pertussis, Measles, Tetanus, Poliomyelitis, Diphtheria, Meningitis, Streptococcus pneumoniae, Meningococcemia without, Hemophilus influenzae, Hepatitis B, Hepatitis C, Malaria, Lower respiratory infections including Influenza, pneumonia, or others
Metabolic
Diabetes
Musculo-skeletal
Osteoarthritis, Rheumatoid arthritis
Respiratory
Asthma, Chronic obstructive pulmonary disease
Skin
Skin diseases
Urogenital
Benign prostatic hypertrophy, Renal failure
|
|
|
|
